Viatris Stock

Viatris Current Liabilities

The Current Liabilities of Viatris (VTRS) as of Aug 14, 2026 is 7.09 B USD. In the previous year, Current Liabilities was 7.99 B USD — a change of -11.18% (lower).

Current Liabilities

7.09 BUSD

YoY

-11.18%

Last updated:

Current Liabilities of Viatris is 2026 7.09 B USD. Current Liabilities of Viatris was 2025 7.99 B USD. It decreases by -11.18% lower compared to the previous year.
Access this data via the Eulerpool API

Viatris Stock analysis

What does Viatris do? Viatris Inc. is a global pharmaceutical company that was formed in 2020 through the merger of Mylan and Upjohn. Headquartered in Pennsylvania, USA, the company operates in over 165 countries. Viatris is one of the largest generic and biosimilar manufacturers worldwide. Viatris is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Viatris stock

Current Liabilities of Viatris is 7.09 B USD in 2026.

Current Liabilities of Viatris changed from 7.99 B USD to 7.09 B USD, representing a -11.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Viatris since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Viatris historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Viatris

All Key Metrics — Viatris